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ABSTRACT
In the use of non-antibody proteins as affinity
reagents, diversity has generally been derived
from oligonucleotide-encoded random amino acids.
Although specific binders of high-affinity have been
selected from such libraries, random oligonuc-
leotides often encode stop codons and amino acid
combinations that affect protein folding. Recently it
has been shown that specific antibody binding loops
grafted into heterologous proteins can confer the
specific antibody binding activity to the created
chimeric protein. In this paper, we examine the use
of such antibody binding loops as diversity ele-
ments. We first show that we are able to graft a
lysozyme-binding antibody loop into green fluores-
cent protein (GFP), creating a fluorescent protein
with lysozyme-binding activity. Subsequently we
have developed a PCR method to harvest random
binding loops from antibodies and insert them at
predefined sites in any protein, using GFP as an
example. The majority of such GFP chimeras remain
fluorescent, indicating that binding loops do not
disrupt folding. This method can be adapted to the
creation of other nucleic acid libraries where divers-
ity is flanked by regions of relative sequence
conservation, and its availability sets the stage for
the use of antibody loop libraries as diversity
elements for selection experiments.
INTRODUCTION
It is believed that a new suite of technologies, generically
termed the ‘display’ technologies will overcome many of
the disadvantages associated with the generation of antibodies
by immunization. In particular, they avoid animals, provide
monoclonal reagents and since genes are cloned simultan-
eously with selection, can be easily manipulated to provide
novel downstream reagents with additional properties.
Although antibody fragments were originally most com-
monly used as scaffolds, many other proteins have also been
used successfully (1,2), with the most widely pursued being
single domains based on the immunoglobulin fold: e.g. single
VH (3) or VL (4) chains, camel VHH domains (5), CTLA4 (6)
or ﬁbronectin (7) domains. In general these tend to be
relatively well expressed (1–10 mg/l) with afﬁnities in the
nanomolar range, although expression in intracellular com-
partments can be difﬁcult due to the presence of disulﬁde
bonds. Beyond immunoglobulin domains, nanomolar binders
have also been selected from libraries based on a three helix
bundle domain from protein A [Afﬁbodies (8,9)], lipocalins
[termed anticalins (10,11)], cysteine rich domains (12) and
ankyrins [termed DARPINS (13,14)], with X-ray crystallo-
graphy (13,15) of anticalins and ankyrins showing that the
mutated residues undergo structural changes, when compared
to the parent molecule, to accomodate binding.
Transformation of a protein into a binding scaffold requires
the introduction of diversity at the site targeted to become the
binding site. This has generally been either replacement
diversity (3–6,8–11,13)—where amino acids present in the
scaffold of interest, within the chosen loops or surfaces, are
randomized—or insertional diversity, where a speciﬁc inser-
tional site is chosen and stretches of random amino acids are
inserted. The latter has been carried out both in antibody
binding loops (16–19) and other proteins (20–24), with
diversity derived from random peptides encoded by degener-
ate oligonucleotides or in rare cases by trinucleotide codons
(25). Recently, antibodies with high afﬁnities have also
been selected from libraries where the introduced comple-
mentarity determining region (CDR) diversity is limited to
only four (tyrosine, alanine, aspartate and serine) (26) or
two (tyrosine and serine) (27) different amino acids at spe-
ciﬁc sites in multiple CDRs.
Nature provides a potential source of functional and well
folding binding elements in the form of the binding loops
which make up the antibody binding site. Antibodies contain
six such binding loops, termed CDRs, which are involved in
forming the antibody binding site. The ﬁrst and second CDRs
in both light and heavy chains are encoded by the germline V
genes and subsequent mutation, while CDR3 is created as a
result of recombination between V and J genes in the case
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(28,29). Further diversity is created by the addition and loss
of nucleotides at the junctions between the recombined
gene segments (30,31) and somatic hypermutation (32).
Structurally, each class of CDRs is similar in size and struc-
ture, with each adopting one or a few distinct or ‘canonical’
conformations (33–35). HCDR3 is an exception, showing
wide variations in length, structure, shape and sequence
(36,37), as well as intrinsic conformational diversity
(38–40), reﬂecting the importance of HCDR3s in antibody
binding speciﬁcity (41,42). Given this data, and the fact
that HCDR3s also contain very few stop codons, they appear
to represent a very effective form of diversity. This conclu-
sion is bolstered by the structural conservation found at the
ends of HCDR3s, revealed by the ﬁnding that the four
N-terminal and six C-terminal residues from different
HCDR3 regions demonstrate <2.75 s r.m.s.d for >99.7% of
all pair-wise comparisons examined (37). As a result,
HCDR3s would be expected to be less disruptive to protein
structure than random peptides of the same length. Further-
more, if a scaffold is able to accept a single HCDR3 at a spe-
ciﬁc site, it is likely that many different HCDR3s can also be
accommodated at that same site.
Although libraries of HCDR3s have never been assessed for
their effects on protein structure, a number of examples of the
use of speciﬁc antibody CDRs as diversity elements able to
transplant binding activity to a heterologous protein have
been described. An HCDR3 from an integrin binding antibody
hasbeen insertedinto anexposedloopintissue-typeplasmino-
gen activator, conferring integrin binding activity to
the plasminogen activator, without eliminating its normal
enzymatic function (43). Similarly, a CDR3 from a camelid
VHH recognizing lysozyme has been transplanted to neocar-
zinostatin,abacterialchromoproteinwithabetasheetstructure,
allowingthechimericmoleculetorecognizelysozyme(44).As
camelid VHH CDR3s are very similar to traditional antibody
HCDR3s, these two examples indicate the potential for using
libraries of HCDR3s as diversity/binding elements, if means
for harvesting that diversity can be developed. More recently,
an HCDR1 loop from a CD4 binding antibody was inserted
into three exposed loops of the protein inhibitor of neuronal
nitric oxide synthase and each construct was shown to exhibit
CD4 binding (45). This work was based on earlier work show-
ing that peptides derived from ﬁve of the six CDRs of the anti-
CD4antibody,andnototherregionsofthevariableregionwere
able to bind CD4 as soluble, circularized peptides (46).
While these experiments show that in these speciﬁc
examples, HCDR3s can be inserted into heterologous pro-
teins without disruption of protein function, it does not dem-
onstrate that this can be carried out generally.
In this paper we explore the possibility of using HCDR3s as
a source of insertional diversity. Using the green ﬂuorescent
protein (GFP), which is not ﬂuorescent unless correctly folded
(47), as a reporter protein, we ﬁrst show that the VHH CDR3
described above is also functional when inserted into two sites
in GFP. Subsequently we describe a novel PCR method to
harvest HCDR3 diversity, based on the fact that the N- and
C-terminal HCDR3 amino acids (CXX...XXWG) are
extremely well conserved at the DNA, protein and structural
levels. We examine the effects of inserting antibody binding
loops ampliﬁed using this method into GFP, and show that
for most sites, and most HCDR3s, there is relatively little dis-
ruption to GFP function, validating HCDR3s as a potential
source of diversity. These experiments set the stage for further
exploration of the use of HCDR3s as diversity elements in a
variety of different scaffold proteins.
MATERIALS AND METHODS
pET-CK3 expression vector construction
Four BpmI sites, one SphI and BssHII site were eliminated
from pET-C6His (48), a pET-28 derivative. The SphI site
was eliminated by digesting pETC6-His with SphI. The linear
DNA fragment was treated with T4 DNA polymerase and
re-ligated with T4 DNA ligase. The ligation was digested
with SphI and transformed into DH5aFT cells. The BpmI
sites and the BssHII site were mutated using the Stratagene
mutagenesis kit (Stratagene, La Jolla, CA) according to the
manufacturer’s recommendation. Brieﬂy, 100 ng of pETC-
His6-DSphI template DNA was ampliﬁed in a 25 ml reaction
using 1 mM of the primers indicated in Table 1. A total of 1 ml
of dNTP mix, 0.75 ml of QuikSolution and 1 mlo f
QuikChange  Multi enzyme blend with the following tem-
perature cycle: 95 C for 1 min followed by 30 cycles of
95 C for 1 min, 55 C for 1 min, 65 C for 10 min. The
PCR product was digest with DpnI, BpmI and BssHII for
1 h and the mixture was transformed into XL-10 Gold 
ultracompetent cells. The resulting pET-CK3 vector was
checked by restriction mapping and sequencing.
SacB insertion into the GFP loops
SacB is a negative selectable marker, which can be used to
kill bacteria bearing by growth on sucrose (49). The SacB
gene was inserted into superfolder GFP (50) at each of the
different identiﬁed loop sites (Table 2) in such a way that it
was ﬂanked by two type BpmI restriction sites. These allowed
the removal of the sacB gene and the creation of an appropri-
ate cloning site for CDR3 sequences, which were also ﬂanked
with compatible BpmI sites. After BpmI cleavage, the N and
C portions of a generic CDR3 were exposed, allowing the
reassembly of a full CDR3 after ligation of ampliﬁed
CDR3 inserts (see Figure 1). Since the sacB gene disrupts
the GFP coding sequence, clones are not ﬂuorescent unless
permissive CDR3s have been inserted. These vectors were
created by amplifying the full pET-CK3-sfGFP plasmid
using pairs of primers ﬂanking each insertion site. This cre-
ated the following structure (illustrated for the insertion at
loop 2), with the portion in green corresponding to GFP,
the portion in red representing the primer encoded sequences
which complement the cloned HCDR3, and the underlined
bases the cleavage site for the indicated BpmI sites:
FKDS G DG
50..TTC AAA GAT TCTG GC GAG GAA TAC TAA CTC CAG AGT AGA CCC TAA TGA TGA GCT GGA GCC TAA AGA CCC GGG GGC GAC GGG..
30..AAG TTT CTA AGA CCG CTC CTT ATG ATT GAG GTC TCA TCT GGG AGG ACT ACT CGA CCT CGG ATT TCT GGG CCC CCG CTG CCC..
BpmI BpmI
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used. These PCR products were cleaved with BpmI and lig-
ated to SacB ampliﬁed with sacB.2-50 and sacB-30 also
cleaved with BpmI (Table 1). These SacB primers placed
BpmI sites at equivalent positions, allowing the SacB gene
to be removed by cleavage with BpmI in the ligated clone.
After cloning, bacteria were tested for their inability to
grow on both liquid and agar media containing 2–5% sucrose,
as well as by restriction digestion.
HCDR3 amplification
Total RNA was prepared from 40 different samples of human
peripheral blood lymphocytes puriﬁed by Ficoll Hypaque
(Amersham Pharmacia Biotech, UK). Pathogens were deemed
to be inactivated by the use of Trizol to purify RNA. This work
was carried out under the auspices of the LANL IRB. cDNA
was synthesized using random hexamers and reverse tran-
scriptase following standard protocols. HCDR3s were ampli-
ﬁed by nested PCR using the IgM for forward primer and a
mixture of VH primers (4–6,10,12,14,22,51) with the follow-
ing temperature cycle: 94 C, 60 s followed by 30 cycles of
94 C, 30 s, 55 C, 30 s, 72 C, 1 min followed by 72 C for
7 min. One microliter of the ﬁrst PCR after gel puriﬁcation
was used as template in the second PCR. Biotinylated primers
in Tables 2–5 were used to amplify the CDR3 sequences with
the following temperature cycle: 94 C, 60 s followed by
30 cycles of 94 C, 30 s, 50 C, 30 s, 72 C, 1 min followed
by 72 C for 7 min. The PCR product was phenol/chloroform
extracted and ethanol precipitated. It was dissolved in 90 mlo f
water and digested with 50 U of BpmI for 2 h. The enzyme
was heat inactivated at 65 C for 20 min. A total of 100 mlo f
M-280 Streptavidin Dynabeads (Dynal, Norway) was washed
three times with TE and the beads were resuspended in the
BpmI digested PCR products. The beads were mixed at
room temperature for 30 min and collected with a magnet.
The supernatant, which contains digested HCDR3s was used
directly in the ligation reactions.
Library construction
pET-CK3-sfGFP-SacB in eight different loops were digested
with BpmI, treated with Antarctic phosphatase and gel puri-
ﬁed using the Qiagen gel puriﬁcation kit. The concentration
of the vector was measured by spectroﬂuorometer and liga-
tions were set up with CDR3 fragment with a vector:insert
ratio of 1:3 overnight at 4 Ci n2 0ml volume using 800 U
of T4 DNA ligase (NEB). tRNA (1 mg) was added to the reac-
tions and the total ethanol precipitated and redissolved in
50 ml of water. A total of 2 ml of each of the ligation reactions
were electroporated into BL21 (DE3) Gold (Novagen) cells
and plated on nitrocellulose ﬁlters on Luria–Bertani (LB)
plates containing 50 mg/ml kanamycin/2% glucose/2% suc-
rose. Cells were grown overnight at 37 C. The ﬁlters were
transferred onto kanamycin LB plates containing 1 mg/ml
isopropyl-b-D-thiogalactopyranoside (IPTG) and induced for
4ha t3 0  C.
Determination of c-lys affinity by flow cytometry
Streptavidin coated beads (50 ml) (Spherotec) were incubated
with either 1 ng of biotinylated (Pierce Biotechnology) lyso-
zyme (Sigma) or 15 ng of biotinylated 9E10 (anti-myc,
Table 1. The sequences of the primers used to create the different recipient GFP vectors
Loop 1 (23/24) and loop 1a (22/24)
TAATGATGAGCTGGAGCCTAAAGACCCGGGGGCGGGCACAAATTTTCTGTCAGAGGAG pDAN5-GFP-loop1-30
GGGTCTACTCTGGAGTTAGTATTCCTCGCCAGAATTAACATCACCATCTAATTCAACAAG pDAN5-GFP-loop1.4-50
GGGTCTACTCTGGAGTTAGTATTCCTCGCCAGAAACATCACCATCTAATTCAACAAG pDAN5-GFP-loop1a.4-50
Loop 2 (102/103) and loop 2a (101/102)
TAATGATGAGCTGGAGCCTAAAGACCCGGGGGCGACGGGACCTACAAGACGCGTGCTG pDAN5-GFP-loop2-30
GGGTCTACTCTGGAGTTAGTATTCCTCGCCAGAATCTTTGAAAGATATAGTGCGTTC pDAN5-GFP-loop2.4-50
TAATGATGAGCTGGAGCCTAAAGACCCGGGGGCGATGACGGGACCTACAAGACGCGTGCTG pDAN5-GFP-loop2a-30
GGGTCTACTCTGGAGTTAGTATTCCTCGCCAGATTTGAAAGATATAGTGCGTTC pDAN5-GFP-loop2a.4-50
Loop 3 (173/174) and loop 3a (172/173)
TAATGATGAGCTGGAGCCTAAAGACCCGGGGGCGGTTCCGTTCAACTAGCAGACCAT pDAN5-GFP-loop3-30
GGGTCTACTCTGGAGTTAGTATTCCTCGCCAGAATCTTCAACGTTGTGGCGAATTTTG pDAN5-GFP-loop3.4-50
TAATGATGAGCTGGAGCCTAAAGACCCGGGGGCGATGGTTCCGTTCAACTAGCAGACCAT pDAN5-GFP-loop3a-30
GGGTCTACTCTGGAGTTAGTATTCCTCGCCAGATTCAACGTTGTGGCGAATTTTG pDAN5-GFP-loop3a.4-50
Loop 4 (213/214)
TAATGATGAGCTGGAGCCTAAAGACCCGGGGGCAAGCGTGACCACATGGTCCTTCTT pDAN5-GFP-loop4-30
GGGTCTACTCTGGAGTTAGTATTCCTCGCCAGATTCGTTGGGATCTTTCGAAAGGACAG pDAN5-GFP-loop4.4-50
Loop 5 (51/52)
TAATGATGAGCTGGAGCCTAAAGACCCGGGGGCAAACTACCTGTTCCATGGCCAACACTTG pDAN5-GFP-loop5-30
GGGTCTACTCTGGAGTTAGTATTCCTCGCCAGATCCAGTAGTGCAAATAAATTTAAGGGTGAG pDAN5-GFP-loop5-50
SacB primers
GGGGGGTCTGGCGAGGAATACTAACTCCAGTTTTTAACCCATCACATATACCTGCCGTTCAC SacB.2-50
GGGGGAACCGCCCCCGGGTCTTTAGGCTCCAGCCGCTTCTCAACCCGGTACGCACCAG SacB-30
Restriction enzyme mutation primers
GCTCGTTGAGTTTCTCAAGAAGCGTTAATGTCTGGC BpmI 2621
CGATCATCGTCGCGCTCAAGCGAAAGCGGTCC BpmI 3288
GACATGGCACTCCAATCGCCTTCCCGTTCCGC BpmI 3922
GCGTGCAGGGCCAGACTAGAGGTGGCAACGCC BpmI 4411
GACTCGGTAATGGCACGCATTGCGCCCAGC BssHII 3288
The portionin green corresponds to GFPand the portionin red, the conservedportionof the HCDR3. Underlinedbases represent restrictionsites(BpmI and SmaI).
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phosphate-buffered saline (PBS), for 1 h at room temperature.
A total of 100 ml of 5% BSA was added to block the bead
surface and incubated for a further hour at room temperature.
Beads were washed once in PBS and resuspended in 150 mlo f
PBS. GFP containing the anti-lysozyme CDR3 with an initial
concentration of 0.6 mg/ml was 2-fold serially diluted and 5
ml of antigen coated beads added to 50 ml diluted protein per
well. After 1 h incubation at room temperature the supernat-
ant was removed by washing once in PBS and the beads were
analyzed by ﬂow cytometry using a FACSAria instrument
(BD Biosciences). For the determination of afﬁnity at each
(a)
(b)
Figure 1. (a) The genetic rearrangement which creates human VH genes, and the PCR strategy used to amplify, digest and purify HCDR3s is shown on the left,
while on the right is shown the general scheme used to create a template for simple insertion of HCDR3s exploiting type IIs restriction sites and a negative
selectable marker, such as SacB. (b) The detailed sequence of a recipient vector containing SacB inserted into loop 2, and the cloning strategy used to insert
HCDR3s. The letters depicted in green represent GFP sequences, black are HCDR3 sequences, and red are junctional sequences which come together during the
ligation procedure. As a result of the cloning procedure, the conserved cysteine present in the HCDR3 is converted into a serine. BpmI R (underlined) identifies
the BpmI recognition site, while BpmI C identifies the cleavage site.
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binding of c-lys to the beads coated with an irrelevant target
was subtracted from the speciﬁc ﬂuorescence of the lysozyme
coated ones. The resulting ﬂuorescence values at each dilu-
tion were ﬁtted to a logistic function using Origin (Microcal
Software, Inc., Northampton, MA) and the afﬁnity determ-
ined as the concentration at which half maximal ﬂuorescence
was obtained (52).
Flow cytometric analysis of bacterial fluorescence
Bacterial libraries expressing GFP clones were inoculated
in minimal medium (53) and grown overnight at 37 C. The
following day 1 ml of autoinduction medium (53) was inocu-
lated with 10 ml of each library and grown at 30 C overnight.
The cells were diluted in PBS and analyzed using a BD LSR
II ﬂow cytometer (BD Biosciences), using the 488 nm laser to
excite GFP).
Protein expression, purification and characterization
All plasmids were transformed into Escherichia coli BL 21
Gold, plated on 2XTY/Kan/10% glucose and grown overnight
at 37 C. Individual colonies were picked and grown overnight
in liquid 2XTY/Kan/Glucose at 37 C. Conﬂuent culture (1 ml)
was used to inoculate 50 ml 2XTY/Kan/IPTG in 250 ml sha-
ker ﬂasks for expression at 30 C overnight.
Proteins were puriﬁed by low-salt immobilized metal afﬁn-
ity chromatography. Cultures were harvested by centrifuga-
tion, sonicated and resuspended in 10 mM Tris.HCl (pH 8.0)
and recentrifuged at 3000 g for 30 min at 4 C. The supernatant
was applied to IMAC columns pre-equilibrated with Tris for
initial adhesion. The ﬂow-through was reapplied three addi-
tional times and washed with 20 bed volumes Tris. An addi-
tional wash of 20 bed volumes of 10 mM Tris/300 mM
NaCl/10% glycerol was performed preceding a ﬁnal Tris
wash before elution in 600 mM Imidazole. The buffers were
exchanged from the eluted proteins using three passes of
spin ﬁltration with 10 000 MWCO Amicon Ultra centrifugal
ﬁltration devices at 4 C. The desalted proteins were diluted
in prechilled Tris and stored at 4 C preceding further evalu-
ation. Protein samples for SDS–PAGE comparison were
diluted for equivalent ﬂuorescence utilizing a Tecan Spectra-
ﬂuor Plus plate ﬂuorometer equipped with 485 nm excitation
and 535 nm emission ﬁlters prior to standard denaturation
and gel loading.
Absorption spectra were collected on a ThermoSpectronic
Genesys2 and exported to Microsoft Excel for comparison.
Excitation and emission spectra were generated by either a
QuantumMaster 6SE (Photon Technologies Incorporated;
Edison, NJ) or a SPEX Fluorolog spectroﬂuorometer utilizing
1c m
2 cuvettes. Excitation scans were evaluated with 509 nm
emissionwavelength. Emission scans were generatedwith 488
nm excitation. All emission scans were normalized to the
maximum value obtained at the main emission peak for each
sample.
Surface plasmon resonance analysis
of anti-lysozyme HCDR3 clones
SPR analysis was performed on a BIAcore 2000, using a
Streptavidin chip (purchased from BIAcore). Our in-house
Table 3. Primer analysis
Primer Sequence Degeneracy Rearranged V Germline V
50 set
VR35-1.4 GCCACRTATTACTGTG 2 123 (72, 51) 3
VR35-2.4 GCCATNTATTACTGTG 4 434 (107, 30, 258, 39) 3
VR35-3.4 GCCGTHTATTACTGTG 3 577 (356, 148, 73) 1
VR35-4.4 GCCTTGTATTACTGTG 1 66 2
VR35-5.4 GCTGTHTATTACTGTG 3 391 (120, 162, 109) 0
VR35-6.4 GCYGTGTATTACTGTG 2 2118 (974, 1144) 35
VR35-7.4 GCYGTVTATTATTGTG 6 303 (33, 36, 95, 23, 49, 67) 0
VR35-8.4 GCYGTNTATTTCTGTG 8 170 (17, 23, 37, 17, 8, 13, 47, 9) 0
Total 4182/5646 74% 44/49 90%
30 set
JH1.4-30 CCAGGGTGCCCTGGCCCCA 1 170 JH4, JH5
JH2.4-30 CCAGGGTGCCACGGCCCCA 1 94 JH6
JH3.4-30 CCATTGTCCCTTGGCCCCA 1 487 JH3
JH4.4-30 CCAGGGTTCCCTGGCCCCA 1 1958 JH1
JH6.4-30 CCGTGGTCCCTTGGCCCCA 1 802 JH2
Total 3511/5646 62% 6/6 100%
Sequencesofthoseportionsofthe50 and30 primerscorrespondingtotheVH orJHgenessuitablefortheamplificationofHCDR3sareshown.Thesewereanalyzed
byusingonlytheportionoftheprimerwhichrecognizestheVorJgeneandsearchingagainstthedatabaseof5646rearrangedVgenesorthe49germlineVgenesor
6 JH genes. These analyses are stringent (100%), so it is likely that in real experimental situations, more sequences are likely to be amplified, as in each case the
30 primer sequences are extremely well conserved. Under ‘Rearranged V’, the total numbers of the 5646 rearranged VH genes downloaded from IMGT with
absolute homology to each of the primers are given. In brackets are given the number of VH genes recognized by each of the individual primers making up the
degenerate pool. Under ‘Germline V’, the number of germline VH genes with 100% homology to the primers is given.
Table 2. GFP insertion sites
Loop Amino acids Loop Amino acids
1 23/24 VN/GH 1a 22/24 DV/N/GH
5 51/52 TG/KL
2 102/103 KD/DG 2a 101/102 FK/DD
3 173/174 ED/GS 3a 172/173 IE/DG
4 213/214 NE/KR
The sites at which HCDR3 libraries were inserted into GFP are indicated. For
loops 1, 2 and 3, two different insertion points were used as shown in the table.
In loop 1a the underlined asparagine was deleted and the HCDR3s inserted
between the valine and the glycine.
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chip (ﬂow cells 1,2,3), and our biotinylated myoglobin was
used as the negative control (non-speciﬁc binding control)
ligand on the same chip (ﬂow cell 4). Approximately 4000
RUs of both ligands were bound to the chip, under which
conditions speciﬁc binding could be demonstrated.
RESULTS
Inserting a defined CDR3 into GFP
to confer binding activity
The HCDR3 from a VHH recognizing lysozyme has been
transplanted to neocarzinostatin, a bacterial chromoprotein
with a beta sheet structure, with the chimeric molecule recog-
nizing lysozyme with an afﬁnity of 500 nM (44). We attemp-
ted to replicate this ﬁnding, by transferring the same HCDR3
to two surface exposed loops in ‘Superfolder’ GFP (sfGFP)
(50), a GFP mutant selected to be resistant to the destabilizing
effects of poorly folding proteins fused to its N-terminus, and
hence more stable than other forms of GFP. In order to effect-
ively use HCDR3s as diversity elements, both structural and
sequence conservation must exist at the N- and C-terminal
ends of the isolated HCDR3. Structural conservation is
required to ensure that once a permissive site has been cho-
sen, different HCDR3s can be inserted equally effectively
at the same site, while sequence conservation is required to
allow effective cloning of the isolated HCDR3s. Within the
four N-terminal and six C-terminal amino acids from differ-
ent HCDR3 regions found to be structurally similar by Morea
et al. (37), the DNA sequences encoding the N-terminal
cysteine and C-terminal tryptophan and glycine are extremely
conserved. As the cysteine 104 [IMGT numbering (54)] usu-
ally forms a double hydrogen bond with the glycine 119 (37),
these two amino acids were chosen to be the limits of the
cloned HCDR3. However, to avoid the presence of an
unpaired cysteine (the HCDR3 N-terminal cysteine normally
disulﬁde bonds with another cysteine in framework one), this
codon was mutated to a serine. This is identical to cysteine,
except for the replacement of sulfur by oxygen, and so is
able to form the same hydrogen bonds. In order to create
recipient GFPs which could be used for cloning HCDR3 lib-
raries, as well the speciﬁc anti-lysozyme HCDR3, we inserted
(see Figure 1 and below) a SacB gene at each targeted inser-
tion site ﬂanked by BpmI sites. The SacB gene is a negative
selector able to reduce vector background by 10
5-fold by plat-
ing bacteria on sucrose after transformation (49,55). BpmI is
a type IIs restriction site which cleaves 14/16 bp away from
its recognition site. The cleavage sites were designed to
include conserved 50- and 30-HCDR3 sequences, which
were exposed after digestion by BpmI, allowing the recon-
struction of full-length HCDR3s within the GFP from either
annealed oligonucleotides or ampliﬁed PCR fragments.
The anti-lysozyme HCDR3 described above was synthes-
ized as a pair of overlapping phosphorylated oligonucleotides.
These were annealed and ligated directly into two of the BpmI
cut vectors (Figure 1). Loops 1 and 3 (see Table 2 for nomen-
clature) were both independently targeted. Both clones, named
c-lys1 and c-lys3, depending upon the loop insertion site,
yielded ﬂuorescent proteins. These were expressed in BL21
using either 100 mM IPTG or autoinduction media (53), and
subsequently puriﬁed by immobilized metal afﬁnity chroma-
tography using the C-terminal His6 tag.
Binding between GFP containing this HCDR3 was demon-
strated in an enzyme-linked immunosorbent assay (ELISA)
format in which the lysozyme was biotinylated and interacted
with the modiﬁed GFP prior to capture on a neutravidin coated
plate (Figure 2A). Speciﬁc binding could also be demonstrated
using a ﬂow cytometric bead based method, inwhich detection
Table 4. Primer localization
VH genes
102 103 104 105 106 107
Y YH C AKT
TAT TAC TGT GCG AGA GA
... C.. ... ... ... ..
... ... ... AA. .A. ..
... ... ... A.T ... C.
... ... ... A.T ... ..
... ... ... A.C .C. ..
... ... ... ..T ... ..
... ... ... ..C ... ..
... ... ... ..A .C. ..
... ... ... ..A .A. ..T
... ... ... ..A ... T.
... ... ... ..A ... ..
... ... ... ... GC. ..
... ... ... ... .A. ..
... ... ... ... ... C.
... ... ... ... ... A.
... ... ... ... ... .G
... ... ... ..A CAC AG
... ... ... ..A C.G AT
——————————> primer set
JH genes
115 116 117 118 119 120 121 122 123 124 125 126 127 128
FM QD W G QR G T MLT V T V S S
JH1 TTC CAG CAC TGG GGC CAG GGC ACC CTG GTC ACC GTC TCC TCA G/
JH2 ... G.T .T. ... ... .GT ... ... ... ... ..T ... ... ... ./
JH3 ..T G.T AT. ... ... ..A ..G ..A A.. ... ... ... ... ... ./
JH4 ..T G.C T.. ... ... ... ..A ... ... ... ... ... ... ... ./
JH5 ... G.C .C. ... ... ... ..A ... ... ... ... ... ... ... ./
JH6 A.G G.C GT. ... ... ..A ..G ... AC. ... ... ... ... ... ./
<————————————————————— primer set
ThesequencesshownrepresentthefulldiversityfoundinthegermlineVgenes
centered around the conserved cysteine (TGT). All six JH sequences are
indicated. For both VH and JH, the region of primer recognition is given,
andthe cutsitewhenBpmIisusedis underlined.TheIMGTnumberingsystem
is used.
Table 5. HCDR3 amplification primer sequences
50 primer sets
VR35-1.450Biotin-AACGTGCTGGAGGCCACRTATTACTGTG
VR35-2.450Biotin-AACGTGCTGGAGGCCATNTATTACTGTG
VR35-3.450Biotin-AACGTGCTGGAGGCCGTHTATTACTGTG
VR35-4.450Biotin-AACGTGCTGGAGGCCTTGTATTACTGTG
VR35-5.450Biotin-AACGTGCTGGAGGCTGTHTATTACTGTG
VR35-6.450Biotin-AACGTGCTGGAGGCYGTGTATTACTGTG
VR35-7.450Biotin-AACGTGCTGGAGGCYGTVTATTATTGTG
VR35-8.450Biotin-AACGTGCTGGAGGCYGTNTATTTCTGTG
30 primer sets
JH1.4-3050Biotin-TGAGGAGACTGGAGCCAGGGTGCCCTGGCCCCA
JH2.4-3050Biotin-TGAGGAGACTGGAGCCAGGGTGCCACGGCCCCA
JH3.4-3050Biotin-TGAAGAGACTGGAGCCATTGTCCCTTGGCCCCA
JH4.4-3050Biotin-TGAGGAGACTGGAGCCAGGGTTCCCTGGCCCCA
JH6.4-3050Biotin-TGAGGAGACTGGAGCCGTGGTCCCTTGGCCCCA
The 50 and 30 primer sequences used are shown. Each primer is biotinylated at
the 50 end. The biotin is followed by four bases to assist in recognition and
cleavage by the type IIs enzyme, BpmI (recognition sequence CTGGAG16/
14). The cut site is underlined.
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coatedbeadstowhichbiotinylatedlysozymeandGFPcontain-
ingtheanti-lysHCDR3hadbound(Figure2B).UnlikeELISA,
this method relies on the intrinsic ﬂuorescence of the binder,
demonstrating that binding activity and ﬂuorescence reside in
thesameprotein,andthat,atleastinthiscase,HCDR3insertion
hasnotdisruptedGFPfunction.Thistechniquecanalsobeused
to determine afﬁnity (52) by incubating microspheres coated
with antigen with increasing concentrations of ﬂuorescent bin-
der. As concentration increases, the bead bound ﬂuorescence
reaches a plateau, as all target sites on the microspheres are
bound. By subtracting background binding and determining
the concentrationofﬂuorescent binderatwhich half maximum
ﬂuorescenceisobtained,wewereabletoestimatetheafﬁnityof
this interaction to be 1.34 mM for c-lys1 (Figure 2C), similar to
the estimate, obtained by isothermal calorimetry, for neocar-
zinostatin containing the same HCDR3 (44). Binding was
also examined using surface plasmon resonance. Although,
speciﬁc binding could be demonstrated when chips were den-
sely coated with lysozyme, similar to the neocarzinostatin res-
ults(44),afﬁnitywasnothighenoughtoshowbindingwhenthe
lowerlevelsofcoatingrequiredtodetermineafﬁnitywereused
(data not shown).
These results indicate that the orientation and structure of
the HCDR3 is maintained at both insertion sites and is similar
to that in the original VHH, suggesting that HCDR3s are a
valid potential source of diversity, and may alone provide
sufﬁcient binding energy to yield micromolar binders.
Analyzing human HCDR3 flanking sequences
In order to determine the best way to clone HCDR3s, 5669
human heavy chain variable genes were downloaded from
the IMGT web site (56), using ‘human heavy chain variable
genes of any speciﬁcity’ as search criteria. These were pared
down to 5646 full-length VH genes representing a wide spec-
trum of different V genes, and encompass the full range of
mutations found at all different sites within the V genes,
including potential primer sites ﬂanking the CDR3. Of
these 5646 VH genes, 4842 can be accounted for by search-
ing for the following motifs (all based on the 10 bases ﬁnish-
ing with the extremely conserved cysteine and the base which
follows it—TGT G) found at the 30 end of framework region
3 just before the CDR3 (number of times found):
TATTACTGTG (4061)
TATTATTGTG (462)
TATTTCTGTG (319)
As ampliﬁcation usually requires more than 10 bases of
homology, the 4842 sequences described above were extrac-
ted from the database and analyzed for homology upstream of
Figure 2. (A) ELISA was carried out by first interacting biotinylated antigen with the GFP clone of interest and then capturing on a neutravidin coated plate. GFP
binding was revealed using SV5, a monoclonal antibody (73), which recognizes a tag appended to the C-terminus. The non-specific clone was GFP containing
the myc epitope (74) at the loop 3 position, and indicates the level of binding due to a similarly disrupted GFP molecule. clyslp1 and clyslp3 have the lysozyme
binding HCDR3 inserted into loop 1 and loop 3, respectively. (B) Streptavidin coated beads were incubated with either biotinylated lysozyme or myoglobin,
(which serves as the negative control for non-specific binding to coupled beads) and subsequently with GFP or GFP containing the anti-lysozyme HCDR3
inserted at loop 1 (c-lys1). Analysis was carried out using a FACSCalibur. (C) As in (B), except that different concentrations of c-lys1 were used and the mean
fluorescence of the non-specific (myoglobin) beads was subtracted from the fluorescence of the lysozyme coated beads and plotted. The affinity is calculated
from the concentration of c-lys1, which gives half maximal fluorescence.
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sequences described in Table 3 were designed. A similar pro-
cedure was carried out for the 30 end of the HCDR3 in the JH
gene sequences. However, in this case, the sequences were
centered around the highly conserved CTGGGGCC sequence
found in all JH genes. The alignment of these sequences with
germline V and J genes is given in Table 4.
Seven of the thirteen primer sequences were degenerate,
with each component sequence recognizing V genes.
Table 3 shows the numbers of the 5646 rearranged and germ-
line VH genes recognized by each of these sequences, assum-
ing 100% homology. In experimental use, it is likely that
many more genes will be recognized by each individual
primer, since single mismatches do not usually prevent
PCR ampliﬁcation, especially when found upstream of nine
homologous bases.
Cloning design
The strategy used to clone HCDR3s ampliﬁed from B cells
into GFP is described in Figure 1a and detailed in
Figure 1b. The GFP recipient vectors contain the SacB
gene ﬂanked by the highly conserved 50 and 30 portion of
the HCDR3. GFP containing SacB at the different insert
sites is non-ﬂuorescent, and the only way ﬂuorescence can be
restored is by removal and replacement of the sacB negative
selector with a sequence that encodes a peptide permissive
for GFP folding at the targeted insertion site. In order to
isolate these sequences, without ﬂanking framework
sequences, and to recreate full-length HCDR3s, a type IIs
restriction site, BpmI, was used. This cuts 16/14 bases
away from its recognition site, allowing it to be placed
upstream of an amplifying oligonucleotide in such a way
that the majority of the oligonucleotide sequence can be
removed after PCR, leaving a 2 bp 30 extension for ligation
(see Figure 1b). Based on the sequences described in
Tables 4 and 5, the BpmI site in the 50 HCDR3 primer was
placed to cleave across the conserved cysteine and adjacent
codon (TGTG) (Tables 4 and 5), while at the 30 end it was
placed to cleave within the conserved tryptophan codon
(TGGGGC). Overhanging bases are underlined in both
cases. Altogether, eight vectors containing SacB insertions
at eight different sites, comprising ﬁve different loops, were
created (Table 2 and below).
In order to eliminate the primer ends removed by BpmI
cleavage (corresponding to the framework sequences), the
oligonucleotides were biotinylated at their 50 ends (Table 5),
allowing their removal with streptavidin Dynabeads.
PCR amplification and cloning
Non-biotinylated primers were tested by amplifying HCDR3s
from the peripheral blood lymphoctye cDNA of 40 donors
using non-biotinylated primers. Using each individual primer
with a pool of the complementary primers yielded a 75–150
bp smear for all primers (Figure 3A and B), which is more
visible for the primers recognizing more rearranged V
genes (e.g. VR-35–36.4). When the length of the primers is
taken into account, this corresponds to HCDR3s ranging
from  20–95 bp, similar to the previously published range
of HCDR3 lengths (36) (24–90 bp and Figure 5).
Biotinylated versions of the primers were created and
pooled for ampliﬁcation before puriﬁcation and cloning.
Unfortunately, primer JH4.4-3 had to be omitted, due to the
sub-optimal quality of the biotinylated primer. Lane 1 in
Figure 3C shows the HCDR3 smear prior to digestion with
BpmI, ranging from 75 to 150 bp (arrow A). After digestion
(lane 2), the smear is reduced in size by 55 bp (range 25–95 bp,
arrow B), corresponding to the primer portions removed by
BpmI, which can be seen as an additional sharp lower band
(arrow C). Lane 3 shows the ﬁnal puriﬁed HCDR3 preparation
after removal of the biotinylated primers using magnetic strep-
tavidin beads (Dynabeads). The extent and intensity of the
smear is essentially identical to that in lane 2, except that
the lower band is eliminated, indicating the efﬁciency of the
use of streptavidin to remove the biotinylated external primer
portions.
HCDR3 libraries
In order to assess the effects of the insertion of many different
HCDR3s on protein folding in general, and GFP folding and
function in particular, ﬁve different loops in GFP were tar-
geted for the insertion of HCDR3 libraries (Table 2). The
insertion sites were identiﬁed by an examination of the struc-
ture of GFP (57), with the goal of placing the HCDR3s at the
tips of the loops, and so hopefully continue the GFP beta
strand structure into the ﬁrst part of the HCDR3. In addition,
one alternative site, differing by a single amino acid, and
consequently slightly off the tip center, was also targeted
for three of the loops (1, 2 and 3 in Table 2), to see whether
insertion within loops had to be precisely localized, or
whether it was sufﬁcient to target a loop, without concern
for the exact insertion sites.
The HCDR3fragmentswere gelpuriﬁed and cloned into the
eight recipient GFP vectors. The libraries were then induced
and analyzed by ﬂow cytometry. Each of the libraries showed
signiﬁcant numbers of ﬂuorescent bacteria (Figure 4) when
induced with IPTG, with loops 1, 1a, 3, 3a and 5 providing
the greatest number, many of which overlapped with the ﬂuor-
escence of bacteria expressing GFP. The mean ﬂuorescence
for these libraries ranged from 10711–25260, while GFP
had a mean ﬂuorescence of 23274. The remaining loops (2,
2a, 4) were less ﬂuorescent (941–2295), although still signiﬁc-
antly more ﬂuorescent than BL21 (mean 61). All the ﬂuores-
cent proﬁles for bacteria containing GFP with inserts were
broader than GFP with a slightly longer tail on the low ﬂuor-
escence portion of the curve. The differences between libraries
inserted at different loops sites differed by as much as 27-fold
(loop 2a compared to loop 1), while the greatest difference
between insertions in the same loop differing by a single
amino acid were in no case greater than 2.5. This suggests
that the primary determinant of ﬂuorescence is the targeted
loop, with the site within the loop playing a lesser role.
Sequence analysis of HCDR3s
302 random clones containing inserts were sequenced to fur-
ther analyze the nature of the cloned diversity. The length dis-
tributions of the HCDR3s (Figure 5) showed a slight increase
in shorter HCDR3s (14–16 amino acid), and a reduction in
longer ones (>21 amino acid) compared to the HCDR3 length
distributions reported in the literature (36). All inserts were in
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logy to HCDR3s (Figure 6a shows representative sequences).
Only 1.3% of the sequences contained stop codons, and 4.8%
lacked the characteristic C(S)....WG HCDR3 sequence.
In addition there were 18 sequences repeated more than once,
corresponding to 5.9% of all sequences. Interestingly, two of
these duplicated HCDR3 sequences were each found in three
different loops (Figure 6b) indicating duplication was present
in the source cDNA, rather than a cloning artifact. This has
been previously observed in sequencing human peripheral
B cell V genes (58), and reﬂects different VH gene pools
with different representations, such as those derived from
recent infections, rather than the saturation of diversity.
A number of clones from each library were picked at
random and analyzed for their ﬂuorescence, and correlated
with the length of the HCDR3 insert. Figure 6c shows the
ﬂuorescence of individual clones expressed as a percentage
of GFP ﬂuorescence, correlated with the length of the inser-
ted HCDR3. As can be seen, the spread of HCDR3s ranges
from 40 to 75 bp, with little correlation between length
and ﬂuorescence, except beyond 80 bp, where ﬂuorescence
is reduced. This indicates that providing the HCDR3 length
is within the normal range (40–75 bp), larger HCDR3s do
not reduce ﬂuorescence more frequently than smaller
HCDR3s.
In order to determine whether there were any differences
between HCDR3s found in strongly ﬂuorescent clones com-
pared to weakly ﬂuorescent ones, bacteria containing the
libraries were ﬂow sorted for ﬂuorescence, and an additional
434 sequences analyzed. Although the length distributions of
the HCDR3s in the unsorted and sorted libraries were
extremely similar (see Figure 5), the percentages of repeated
sequences (1.6%), non-characteristic HCDR3 sequences (2%)
and sequences containing stop codons (0.7%) were all
reduced.
Examination of protein properties
A number of ﬂuorescent clones containing HCDR3 inserts
were expressed and puriﬁed to study their properties com-
pared to GFP. The expected size differences between GFP
and clones containing inserts were apparent for all clones
(Figure 7a). The expression levels of the different clones
ranges from 5.2–138 mg/l, 1.3–30% the level of GFP.
Normalized absorption/emission spectra were essentially
identical to GFP (data not shown).
The stability of some of these proteins was studied using
a real time PCR machine in which protein ﬂuorescence was
monitored as temperature was gradually raised (0.1 C/s)
(59). Figure 7d shows ﬂuorescence levels for GFP and a
Figure 3. PCR amplification of lymphocyte cDNA using a mixture of the 30 J region primers and individual 50 V gene primers (a), or a mixture of the 50 V gene
primers and the individual J region primers (b). In (c), the pooled PCR product prior to digestion is shown in lane 1. In lane 2 the PCR product after digestion
with BpmI, and in lane 3 the product after the biotinylated primers are removed. In each case the arrows show the amplified HCDR3s except C in 3c.
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escent level. All proteins, with the exception of 2-G2, showed
two phase melting curves with an initial slow phase for
15–30 C after 50 C, followed by a sharp transition to com-
plete melting. The midpoint of the cooperative transition
for GFP was 83.5 C, while clones containing HCDR3 inserts
ranged from  71–83.5 C, with two clones (3a-A12 and
3a-C4) slightly more stable than GFP. By 88.5 C all clones
had completely lost ﬂuorescence. This melting pattern is sim-
ilar to that shown by the engineered ankyrins, with a less
steep ﬁrst phase than that seen with the ankyrins (60).
Although not examined in detail, the proteins with the
lower thermal stabilities tended to come from the less ﬂuor-
escent libraries (loops 2, 2a and 4).
DISCUSSION
Antibody CDRs, or hypervariable regions, are the portions of
the variable regions, which constitute the antigen binding
loops. Of the six CDRs, the HCDR3 is the most diverse,
reﬂecting its complex genetic origin (Figure 1). It also
plays the most important role in antigen recognition, as
shown by the isolation of pairs of antibodies recognizing
different antigens which differ only in their HCDR3s
(41,42). This has not been shown for any of the other
CDRs, indicating that HCDR3s alone, within the context of
an antibody variable domain, are able to provide sufﬁcient
binding afﬁnity to discriminate between different antigens.
Furthermore, it has recently been shown that some antibodies
are able to bind distinctly different antigens as a result of con-
formational ﬂexibility, in which the HCDR3 undergoes large
structural changes when binding (38), a property likely to be
far more widespread than hitherto expected. Coupled with the
known length (36), chemical (36) and structural (37) diversity
of HCDR3s, as well as the relative lack of stop codons, these
results indicate that HCDR3s may serve as useful sources of
diversity if ways could be found to transplant them from anti-
bodies to alternative scaffolds with different properties. In
this regard, a tissue plasminogen activator (TPA) able to
recognize integrins avb3 and aIIbb3 was created by inserting
the HCDR3 from a recombinant anti-integrin antibody (61)
into a TPA loop ﬂanked by a beta sheet structure (43), and
a functional neocarzinostatin derivative able to recognize
lysozyme was similarly created by grafting an HCDR3
from a camelid anti-lysozyme VHH to a surface loop (44).
In the ﬁrst experiments reported here, we were also able to
transfer this VHH CDR3 to two different GFP loops and con-
fer lysozyme-binding with an afﬁnity comparable to that
obtained when transferred into neocarzinostatin, indicating
the generality of transferring HCDR3s with speciﬁc binding
properties to alternative scaffolds.
The main problem with isolating libraries of HCDR3s,
rather than speciﬁc ones, is the fact that their diversity is
embedded within relatively conserved structured beta sheet
framework regions that form extensive contacts with other
Figure 4. Flow cytometric analysis of bacteria containing GFP with HCDR3 libraries at different insertion positions. In each panel the grey line represents
BL21 bacteria, and the green line BL21 expressing GFP. Each panel represents libraries inserted at a different loop, with different positions indicated for loops
1, 2 and 3. The mean fluorescence for each of the populations, calculated from the plots, is given in the table.
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problem with a PCR based method that uses ﬂanking type
IIs restriction sites to remove the framework regions after
ampliﬁcation. This relies on the structural, DNA and amino
acid sequence conservation found at either end of human
HCDR3s: cysteine 104 and tryptophan 119 (IMGT number-
ing) are essentially 100% conserved at the amino acid and
nucleotide levels. Structurally these amino acids are joined
by two hydrogen bonds and so very close to one another, pro-
viding further justiﬁcation for their use as diversity elements.
This allowed us to design 13 primers annealing within the
ﬂanking framework regions which were able to amplify a
large percentage of rearranged VH gene CDR3s. By adding
BpmI sites at the ends of the primers, these framework
Figure 5. The length distribution of cloned HCDR3s derived from bacterial libraries, which were unsorted (blue), or sorted for fluorescence (red), with published
distributions (36) in green.
Figure 6. (a) Shows the sequence of random HCDR3s cloned into the different loops. In (b) are shown two HCDR3 sequences whose sequences were found in
different loops. (c) Shows the correlation between HCDR3 length and bacterial fluorescence as expressed as a percentage of the fluorescence of bacteria
expressing GFP.
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residing within the conserved amino acids at either end of
the HCDR3. These overhangs were ligated to sequences
encoding the remaining portion of the HCDR3 (with the
cysteine exchanged for serine), exposed when the negative
selector (SacB) gene was removed from GFP by digestion
with BpmI (Figure 1). This arrangement facilitated the clon-
ing of a diverse set of HCDR3s, independently of knowledge
of their sequences.
By inserting HCDR3 libraries into the tips of ﬁve loops on
one end of GFP, we were able to assess the degree of disturb-
ance these HCDR3s caused to folding, since GFP must fold
correctly to become ﬂuorescent (47). Of the eight sites
examined, ﬁve were very permissive, giving mean bacterial
ﬂuorescence proﬁles within 2.3-fold of GFP. The remaining
three sites, although up to 25-fold less ﬂuorescent than GFP,
were nevertheless signiﬁcantly ﬂuorescent. The mean ﬂuores-
cence per cell is a combination of the number of ﬂuorescent
proteins per cell and the intrinsic ﬂuorescence of those
ﬂuorescent proteins. In Figure 7a, the amount of each ﬂuores-
cent protein loaded on the polyacrylamide gel was normalized
for ﬂuorescence. The similar intensity of the coomassie blue
staining suggests that the greatest variability between different
bacterial clones is in the amount of expressed ﬂuorescent
protein, rather than any difference in intrinsic ﬂuorescence.
This is supported by the differing levels of protein which
can be puriﬁed from each clone.
For three of the sites (loops 1, 2 and 3) two insertion sites
were tested. These differed by a single amino acid, and the
rationale was to determine whether it was sufﬁcient to
place the HCDR3 within a permissive loop, or whether the
exact site within that loop was critical. Although there was
a small (<2.5-fold) difference in the ﬂuorescence at the two
sites for each loop, this was far less than the difference
observed between different loops (up to 27-fold), suggesting,
at least within this small set, that the loop targeted is more
important than the precise position within the loop. We did
not examine insertion at other sites, and it is possible that
(a)
(b)
Figure 7. (a) Shows a polyacrylamide gel of different purified clones containing HCDR3 inserts at different positions. (b) Shows the normalized fluorescent
emission of different clones gradually heated up at the rate of 0.1 C/second. For each clone, the first figure indicates the loop insertion site.
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loops, or perhaps at the loop extremities, may be signiﬁcantly
more disruptive, especially since loops tend to be less well
conserved than more structured elements.
We sequenced over 300 cloned HCDR3s. Over 90% had
the characteristic HCDR3 sequence: C(S)XX...XXWG.
The sequence characteristics of HCDR3s more permissive
for GFP ﬂuorescence were identiﬁed by ﬂow sorting bacteria
expressing GFP containing HCDR3 libraries in different
loops. We found that HCDR3s in the more ﬂuorescent clones
were less likely to contain stop codons, non-characteristic or
repeated HCDR3 sequences. There was no bias in favor of
either bulged or non-bulged HCDR3s (37), with the propor-
tion remaining constant before and after sorting. As both
non-characteristic and repeated HCDR3s are more likely to
be derived from heavily mutated clones, this may explain
their detrimental effect on GFP ﬂuorescence.
GFP is known to be an extremely stable protein. The GFP
we used, superfolder (50), was selected to be particularly
resistant to the effects of poorly folding proteins fused to
its N-terminus. This also confers improved stability to the
protein generally (50). This was conﬁrmed in our thermal sta-
bility studies, in which the cooperative transition midpoint
was 83.5 C, not dissimilar to GFP containing loops which
ranged from 71 to 83.5 C. This minimal disturbance likely
reﬂects both the stability of GFP as well as the relatively
non-perturbing nature of the HCDR3 inserts, which was
also shown by the fact that the spectral properties of these
proteins were essentially identical to GFP.
This study was carried out with human HCDR3s because
of the great deal of sequencing information available. This
made the design of appropriate framework primers relatively
straightforward. However, with sufﬁcient information on the
sequences of appropriate ﬂanking regions, this approach
could be applied to the harvesting of diversity from the anti-
body genes of other species. This may be of more than aca-
demic interest, since the means by which antibody diversity
has evolved in different species, although sharing some com-
monalities, has tended to be species-speciﬁc (62,63). As a res-
ult, different CDRs have different properties, lengths and
amino acid distributions in different species, with tendencies
to bind to different classes of antigens. Cow (64) and drom-
edary heavy chain genes (65,66), e.g. have far longer
HCDR3s than humans. In camels, these have been shown
to be important in the mediation of enzyme inhibition by dir-
ect insertion into active sites (67,68), as well the recognition
of conserved cryptic epitopes of infectious agents, perhaps by
penetration into conserved receptor binding sites (69).
Although less dramatically different, murine HCDR3s tend
to be shorter than human HCDR3s, with different amino
acid compositions (36), resulting in more HCDR3s which
have stabilized hydrogen bond ladder structures, as opposed
to human HCDR3s which contain more prolines, preventing
the formation of such ladders.
The method we describe here can also be adapted to other
antibody CDRs, as well as to other immunological proteins,
such as T cell receptors, which share similar primary struc-
tures: variable regions ﬂanked by relatively conserved frame-
work regions. g and d TCRs have CDR3s which resemble
immunoglobulin heavy chain CDR3s in their length variabil-
ity, while a and b TCRs have CDR3s, which are extremely
homogenous in length (8–9 amino acids), in common with
the other antibody CDRs (70). The common component of
all such diversity elements is that they have evolved to
bind, and so are likely to be more functional than random
peptides, which generally contain more stop codons and are
more likely to contain destabilizing inserts.
An alternative to the use of completely random amino
acids, has been the use of restricted amino acid sets in the
generation of antibody libraries (26,27,71,72). In these
experiments it has been shown that different amino acid
diversities at speciﬁc sites signiﬁcantly affect the successful
outcome of selection experiments, and in one of the most sur-
prising results, speciﬁc high afﬁnity antibodies can be selec-
ted from libraries in which heavy chain diversity is limited to
only two amino acids (27). These careful studies of the roles
of different amino acids in functional diversity, are similar to
those which nature has been conducting over evolutionary
time in the different molecules involved in immune recogni-
tion in many different species. The method described here
enables the harvesting of such diversity for transplantation
into heterologous proteins, setting the stage for the explora-
tion of the use of libraries containing such sequences for
selection experiments.
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